TY - JOUR
T1 - Clinical Advances in Obsessive Compulsive Disorder: A Position Statement by the International College of Obsessive Compulsive Spectrum Disorders
AU - Fineberg, Naomi
AU - Hollander, Eric
AU - Pallanti, Stefano
AU - Walitza, Susanne
AU - Grünblatt, Edna
AU - Dell'Osso, Bernardo
AU - Albert, Umberto
AU - Geller, Daniel
AU - Brakoulias, Vlasios
AU - Reddy, Janardhan Y C
AU - Arumugham, Shyam Sundar
AU - Shavitt, Roseli G.
AU - Drummond, Lynne
AU - Grancini, Benedetta
AU - De Carlo, Vera
AU - Cinosi, Eduardo
AU - Chamberlain, Samuel R.
AU - Ioannidis, Konstantinos
AU - Rodriguez, Carolyn
AU - Garg, Kabir
AU - Castle, David
AU - Van Ameringen, Michael
AU - Stein, Dan J.
AU - Carmi, Lior
AU - Zohar, Joseph
AU - Menchon Magrina, Jose
N1 - © 2020 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CC-BY-NC-ND - https://creativecommons.org/licenses/by-nc-nd/4.0/), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
PY - 2020/7
Y1 - 2020/7
N2 - In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.
AB - In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.
U2 - 10.1097/YIC.0000000000000314
DO - 10.1097/YIC.0000000000000314
M3 - Article
SN - 0268-1315
VL - 35
SP - 173
EP - 193
JO - International Clinical Psychopharmacology
JF - International Clinical Psychopharmacology
IS - 4
ER -